APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Inhaled Nitric Oxide

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

Selected research

Market Outlook & Growth Opportunities

Global Inhaled Nitric Oxide Market Outlook and Growth Opportunities 2026

Report ID 174002900426 December 2025194 pages

Choose your research edition.

Industry ResearchInhaled Nitric Oxide Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhaled Nitric Oxide Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Inhaled Nitric Oxide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhaled Nitric Oxide Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhaled Nitric Oxide Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

Mallinckrodt monopolizes the global Inhaled Nitric Oxide market, holding a share about 65%.

Read the full market overview

North America is the largest market, with a share about 77%, followed by Asia-Pacific and Europe, have a share about 20 percent.

In terms of product, 800 ppm is the largest segment, with a share over 50%. And in terms of application, the largest application is Near-term and Pre-term Infants PPHN, followed by Children and Adult ARDS, etc.

This report provides an overview of the global Inhaled Nitric Oxide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhaled Nitric Oxide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhaled Nitric Oxide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhaled Nitric Oxide market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhaled Nitric Oxide Segment by Company

Mallinckrodt

Praxair (Linde plc)

Air Liquide

BOC Healthcare (Linde Group)

Inhaled Nitric Oxide Segment by Type

800 ppm

100 ppm

Others

Inhaled Nitric Oxide Segment by Application

Near-term and Pre-term Infants PPHN

Children and Adult ARDS

Other Diseases

Inhaled Nitric Oxide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Inhaled Nitric Oxide status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Inhaled Nitric Oxide market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Inhaled Nitric Oxide significant trends, drivers, influence factors in global and regions.

6. To analyze Inhaled Nitric Oxide competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaled Nitric Oxide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhaled Nitric Oxide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaled Nitric Oxide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhaled Nitric Oxide market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Inhaled Nitric Oxide industry.

Chapter 3: Detailed analysis of Inhaled Nitric Oxide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Inhaled Nitric Oxide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Inhaled Nitric Oxide in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Inhaled Nitric Oxide Industry Trends Table 2. Inhaled Nitric Oxide Industry Drivers Table 3. Inhaled Nitric Oxide Industry Opportunities and Challenges Table 4. Inhaled Nitric Oxide Industry Restraints Table 5. Global Inhaled Nitric Oxide Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Inhaled Nitric Oxide Revenue Share by Company (2021-2026) Table 7. Global Inhaled Nitric Oxide Sales Volume by Company (M L) & (2021-2026) Table 8. Global Inhaled Nitric Oxide Sales Volume Share by Company (2021-2026) Table 9. Global Inhaled Nitric Oxide Average Price (US$/L) of Company (2021-2026) Table 10. Global Inhaled Nitric Oxide Company Ranking, (2024-2026) & (USD Million) Table 11. Global Inhaled Nitric Oxide Key Company Manufacturing Base & Headquarters Table 12. Global Inhaled Nitric Oxide Company, Product Type & Application Table 13. Global Inhaled Nitric Oxide Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Inhaled Nitric Oxide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 800 ppm Table 18. Significant Companies of 100 ppm Table 19. Significant Companies of Others Table 20. Global Inhaled Nitric Oxide Sales Volume by Type 2021 VS 2025 VS 2032 (M L) Table 21. Global Inhaled Nitric Oxide Sales Volume by Type (2021-2026) & (M L) Table 22. Global Inhaled Nitric Oxide Sales Volume by Type (2027-2032) & (M L) Table 23. Global Inhaled Nitric Oxide Sales Volume Share by Type (2021-2026) Table 24. Global Inhaled Nitric Oxide Sales Volume Share by Type (2027-2032) Table 25. Global Inhaled Nitric Oxide Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Inhaled Nitric Oxide Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Inhaled Nitric Oxide Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Inhaled Nitric Oxide Sales Value Share by Type (2021-2026) Table 29. Global Inhaled Nitric Oxide Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Near-term and Pre-term Infants PPHN Table 31. Significant Companies of Children and Adult ARDS Table 32. Significant Companies of Other Diseases Table 33. Global Inhaled Nitric Oxide Sales Volume by Application 2021 VS 2025 VS 2032 (M L) Table 34. Global Inhaled Nitric Oxide Sales Volume by Application (2021-2026) & (M L) Table 35. Global Inhaled Nitric Oxide Sales Volume by Application (2027-2032) & (M L) Table 36. Global Inhaled Nitric Oxide Sales Volume Share by Application (2021-2026) Table 37. Global Inhaled Nitric Oxide Sales Volume Share by Application (2027-2032) Table 38. Global Inhaled Nitric Oxide Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Inhaled Nitric Oxide Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Inhaled Nitric Oxide Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Inhaled Nitric Oxide Sales Value Share by Application (2021-2026) Table 42. Global Inhaled Nitric Oxide Sales Value Share by Application (2027-2032) Table 43. Global Inhaled Nitric Oxide Sales by Region: 2021 VS 2025 VS 2032 (M L) Table 44. Global Inhaled Nitric Oxide Sales by Region (2021-2026) & (M L) Table 45. Global Inhaled Nitric Oxide Sales Market Share by Region (2021-2026) Table 46. Global Inhaled Nitric Oxide Sales by Region (2027-2032) & (M L) Table 47. Global Inhaled Nitric Oxide Sales Market Share by Region (2027-2032) Table 48. Global Inhaled Nitric Oxide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Inhaled Nitric Oxide Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Inhaled Nitric Oxide Sales Value Share by Region (2021-2026) Table 51. Global Inhaled Nitric Oxide Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Inhaled Nitric Oxide Sales Value Share by Region (2027-2032) Table 53. Global Inhaled Nitric Oxide Market Average Price (US$/L) by Region (2021-2026) Table 54. Global Inhaled Nitric Oxide Market Average Price (US$/L) by Region (2027-2032) Table 55. Global Inhaled Nitric Oxide Sales by Country: 2021 VS 2025 VS 2032 (M L) Table 56. Global Inhaled Nitric Oxide Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Inhaled Nitric Oxide Sales by Country (2021-2026) & (M L) Table 58. Global Inhaled Nitric Oxide Sales Market Share by Country (2021-2026) Table 59. Global Inhaled Nitric Oxide Sales by Country (2027-2032) & (M L) Table 60. Global Inhaled Nitric Oxide Sales Market Share by Country (2027-2032) Table 61. Global Inhaled Nitric Oxide Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Inhaled Nitric Oxide Sales Value Market Share by Country (2021-2026) Table 63. Global Inhaled Nitric Oxide Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Inhaled Nitric Oxide Sales Value Market Share by Country (2027-2032) Table 65. Mallinckrodt Company Information Table 66. Mallinckrodt Business Overview Table 67. Mallinckrodt Inhaled Nitric Oxide Sales (M L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 68. Mallinckrodt Inhaled Nitric Oxide Product Portfolio Table 69. Mallinckrodt Recent Development Table 70. Praxair (Linde plc) Company Information Table 71. Praxair (Linde plc) Business Overview Table 72. Praxair (Linde plc) Inhaled Nitric Oxide Sales (M L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 73. Praxair (Linde plc) Inhaled Nitric Oxide Product Portfolio Table 74. Praxair (Linde plc) Recent Development Table 75. Air Liquide Company Information Table 76. Air Liquide Business Overview Table 77. Air Liquide Inhaled Nitric Oxide Sales (M L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 78. Air Liquide Inhaled Nitric Oxide Product Portfolio Table 79. Air Liquide Recent Development Table 80. BOC Healthcare (Linde Group) Company Information Table 81. BOC Healthcare (Linde Group) Business Overview Table 82. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales (M L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 83. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product Portfolio Table 84. BOC Healthcare (Linde Group) Recent Development Table 85. Key Raw Materials Table 86. Raw Materials Key Suppliers Table 87. Inhaled Nitric Oxide Distributors List Table 88. Inhaled Nitric Oxide Customers List Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. Inhaled Nitric Oxide Product Image Figure 2. Global Inhaled Nitric Oxide Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhaled Nitric Oxide Sales Value (2021-2032) & (US$ Million) Figure 4. Global Inhaled Nitric Oxide Sales (2021-2032) & (M L) Figure 5. Global Inhaled Nitric Oxide Sales Average Price (US$/L) & (2021-2032) Figure 6. Global Inhaled Nitric Oxide Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 800 ppm Image Figure 10. 100 ppm Image Figure 11. Others Image Figure 12. Global Inhaled Nitric Oxide Sales Volume by Type (2021 VS 2025 VS 2032) & (M L) Figure 13. Global Inhaled Nitric Oxide Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Inhaled Nitric Oxide Sales Volume Share by Type (2021-2032) Figure 15. Global Inhaled Nitric Oxide Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Inhaled Nitric Oxide Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Inhaled Nitric Oxide Sales Value Share by Type (2021-2032) Figure 18. Near-term and Pre-term Infants PPHN Image Figure 19. Children and Adult ARDS Image Figure 20. Other Diseases Image Figure 21. Global Inhaled Nitric Oxide Sales Volume by Application (2021 VS 2025 VS 2032) & (M L) Figure 22. Global Inhaled Nitric Oxide Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Inhaled Nitric Oxide Sales Volume Share by Application (2021-2032) Figure 24. Global Inhaled Nitric Oxide Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Inhaled Nitric Oxide Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Inhaled Nitric Oxide Sales Value Share by Application (2021-2032) Figure 27. Global Inhaled Nitric Oxide Sales by Region: 2021 VS 2025 VS 2032 (M L) Figure 28. Global Inhaled Nitric Oxide Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Inhaled Nitric Oxide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Inhaled Nitric Oxide Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Inhaled Nitric Oxide Sales Value (2021-2032) & (US$ Million) Figure 32. North America Inhaled Nitric Oxide Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Inhaled Nitric Oxide Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Inhaled Nitric Oxide Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Inhaled Nitric Oxide Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Inhaled Nitric Oxide Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Inhaled Nitric Oxide Sales Value (2021-2032) & (US$ Million) Figure 38. South America Inhaled Nitric Oxide Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Inhaled Nitric Oxide Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Inhaled Nitric Oxide Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Inhaled Nitric Oxide Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Inhaled Nitric Oxide Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 800 ppm
  • 100 ppm
  • Others
Applications
  • Near-term and Pre-term Infants PPHN
  • Children and Adult ARDS
  • Other Diseases
Companies covered
  • Mallinckrodt
  • Praxair (Linde plc)
  • Air Liquide
  • BOC Healthcare (Linde Group)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inhaled Nitric Oxide Sales Value (2021-2032)
  4. 1.2.2 Global Inhaled Nitric Oxide Sales Volume (2021-2032)
  5. 1.2.3 Global Inhaled Nitric Oxide Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Inhaled Nitric Oxide Market Dynamics
  1. 2.1 Inhaled Nitric Oxide Industry Trends
  2. 2.2 Inhaled Nitric Oxide Industry Drivers
  3. 2.3 Inhaled Nitric Oxide Industry Opportunities and Challenges
  4. 2.4 Inhaled Nitric Oxide Industry Restraints
3 Inhaled Nitric Oxide Market by Company
  1. 3.1 Global Inhaled Nitric Oxide Company Revenue Ranking in 2025
  2. 3.2 Global Inhaled Nitric Oxide Revenue by Company (2021-2026)
  3. 3.3 Global Inhaled Nitric Oxide Sales Volume by Company (2021-2026)
  4. 3.4 Global Inhaled Nitric Oxide Average Price by Company (2021-2026)
  5. 3.5 Global Inhaled Nitric Oxide Company Ranking (2024-2026)
  6. 3.6 Global Inhaled Nitric Oxide Company Manufacturing Base and Headquarters
  7. 3.7 Global Inhaled Nitric Oxide Company Product Type and Application
  8. 3.8 Global Inhaled Nitric Oxide Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Inhaled Nitric Oxide Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Inhaled Nitric Oxide Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Inhaled Nitric Oxide Market by Type
  1. 4.1 Inhaled Nitric Oxide Type Introduction
  2. 4.1.1 800 ppm
  3. 4.1.2 100 ppm
  4. 4.1.3 Others
  5. 4.2 Global Inhaled Nitric Oxide Sales Volume by Type
  6. 4.2.1 Global Inhaled Nitric Oxide Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Inhaled Nitric Oxide Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Inhaled Nitric Oxide Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Inhaled Nitric Oxide Sales Value by Type
  10. 4.3.1 Global Inhaled Nitric Oxide Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Inhaled Nitric Oxide Sales Value by Type (2021-2032)
  12. 4.3.3 Global Inhaled Nitric Oxide Sales Value Share by Type (2021-2032)
5 Inhaled Nitric Oxide Market by Application
  1. 5.1 Inhaled Nitric Oxide Application Introduction
  2. 5.1.1 Near-term and Pre-term Infants PPHN
  3. 5.1.2 Children and Adult ARDS
  4. 5.1.3 Other Diseases
  5. 5.2 Global Inhaled Nitric Oxide Sales Volume by Application
  6. 5.2.1 Global Inhaled Nitric Oxide Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Inhaled Nitric Oxide Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Inhaled Nitric Oxide Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Inhaled Nitric Oxide Sales Value by Application
  10. 5.3.1 Global Inhaled Nitric Oxide Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Inhaled Nitric Oxide Sales Value by Application (2021-2032)
  12. 5.3.3 Global Inhaled Nitric Oxide Sales Value Share by Application (2021-2032)
6 Inhaled Nitric Oxide Regional Sales and Value Analysis
  1. 6.1 Global Inhaled Nitric Oxide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhaled Nitric Oxide Sales by Region (2021-2032)
  3. 6.2.1 Global Inhaled Nitric Oxide Sales by Region: 2021-2026
  4. 6.2.2 Global Inhaled Nitric Oxide Sales by Region (2027-2032)
  5. 6.3 Global Inhaled Nitric Oxide Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Inhaled Nitric Oxide Sales Value by Region (2021-2032)
  7. 6.4.1 Global Inhaled Nitric Oxide Sales Value by Region: 2021-2026
  8. 6.4.2 Global Inhaled Nitric Oxide Sales Value by Region (2027-2032)
  9. 6.5 Global Inhaled Nitric Oxide Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Inhaled Nitric Oxide Sales Value (2021-2032)
  12. 6.6.2 North America Inhaled Nitric Oxide Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Inhaled Nitric Oxide Sales Value (2021-2032)
  15. 6.7.2 Europe Inhaled Nitric Oxide Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Inhaled Nitric Oxide Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Inhaled Nitric Oxide Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Inhaled Nitric Oxide Sales Value (2021-2032)
  21. 6.9.2 South America Inhaled Nitric Oxide Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Inhaled Nitric Oxide Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Inhaled Nitric Oxide Sales Value Share by Country, 2025 VS 2032
7 Inhaled Nitric Oxide Country-level Sales and Value Analysis
  1. 7.1 Global Inhaled Nitric Oxide Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Inhaled Nitric Oxide Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Inhaled Nitric Oxide Sales by Country (2021-2032)
  4. 7.3.1 Global Inhaled Nitric Oxide Sales by Country (2021-2026)
  5. 7.3.2 Global Inhaled Nitric Oxide Sales by Country (2027-2032)
  6. 7.4 Global Inhaled Nitric Oxide Sales Value by Country (2021-2032)
  7. 7.4.1 Global Inhaled Nitric Oxide Sales Value by Country (2021-2026)
  8. 7.4.2 Global Inhaled Nitric Oxide Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Inhaled Nitric Oxide Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Inhaled Nitric Oxide Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Inhaled Nitric Oxide Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Mallinckrodt
  2. 8.1.1 Mallinckrodt Company Information
  3. 8.1.2 Mallinckrodt Business Overview
  4. 8.1.3 Mallinckrodt Inhaled Nitric Oxide Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Mallinckrodt Inhaled Nitric Oxide Product Portfolio
  6. 8.1.5 Mallinckrodt Recent Developments
  7. 8.2 Praxair (Linde plc)
  8. 8.2.1 Praxair (Linde plc) Company Information
  9. 8.2.2 Praxair (Linde plc) Business Overview
  10. 8.2.3 Praxair (Linde plc) Inhaled Nitric Oxide Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Praxair (Linde plc) Inhaled Nitric Oxide Product Portfolio
  12. 8.2.5 Praxair (Linde plc) Recent Developments
  13. 8.3 Air Liquide
  14. 8.3.1 Air Liquide Company Information
  15. 8.3.2 Air Liquide Business Overview
  16. 8.3.3 Air Liquide Inhaled Nitric Oxide Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Air Liquide Inhaled Nitric Oxide Product Portfolio
  18. 8.3.5 Air Liquide Recent Developments
  19. 8.4 BOC Healthcare (Linde Group)
  20. 8.4.1 BOC Healthcare (Linde Group) Company Information
  21. 8.4.2 BOC Healthcare (Linde Group) Business Overview
  22. 8.4.3 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product Portfolio
  24. 8.4.5 BOC Healthcare (Linde Group) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inhaled Nitric Oxide Value Chain Analysis
  2. 9.1.1 Inhaled Nitric Oxide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inhaled Nitric Oxide Sales Mode & Process
  6. 9.2 Inhaled Nitric Oxide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inhaled Nitric Oxide Distributors
  9. 9.2.3 Inhaled Nitric Oxide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst